Outlook Therapeutics, Inc. (OTLK): DEFA14A filed Jul 10, 2026

Form type

DEFA14A

Filing date

Jul 10, 2026

Accession number

0001104659-26-082361

Filer

Outlook Therapeutics, Inc. (CIK 1649989)